Rocket Lab Corporation (RKLB) financials
NASDAQ · Industrials · Aerospace & Defense · 2,600 employees · CEO Sir Peter Beck
- Price
- $54.73 -7.39%
- Market cap
- $32.8B
- Enterprise value
- $30.8B
- Last report
- Q2 '26 filed 2026-08-10
- Next report
- 2026-11-09 EPS est. -$0.07
Valuation & key figures
- Market cap
- $32.8B EV $30.8B
- Revenue
- $769M Trailing 12 months
- Revenue growth
- +59% FY2026 consensus
- Profit margin
- -21.5% Net income / revenue, TTM
- P/E
- -197.7× Forward -191.4× (FY2026)
- P/S
- 42.6× Price / sales, TTM
- EV / EBITDA
- -252.1× TTM
- Free cash flow
- -$371M Trailing 12 months
- Net income
- -$165M Trailing 12 months
- Revenue estimate
- $959M FY2026 consensus
- Earnings
- 2026-11-09 Revenue est. $257M
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-10): revenue beat by 1.1%, EPS missed by 37.2%Revenue $234M vs $232M expected (+1.1%); EPS -$0.08 vs -$0.06 (-37.2%).
- Revenue growth accelerating: 62.0% year on yearQ2 '26 revenue $234M, against an average of 45.8% over the four quarters before.
- Operating margin -29.1% (TTM), +15.0 pp on a year agoOperating income grew -0.5% while revenue grew 52.5%.
- Capex 19.3% of revenue (a year ago 18.5%)$149M invested in the last 4 quarters (+59.4% on a year earlier). Free cash flow -$371M.
- Diluted share count up 22.2% in a year630M diluted shares in Q2 '26, 515M a year earlier.
- Net cash $2.17BCash + short-term investments $2.3B, debt incl. leases $134M; a year ago net cash $190M.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $234M | $144M | +62.0% |
| Gross margin | 36.1% | 32.1% | +4.0 pp |
| Operating income | -$57.5M | -$59.6M | +3.6% |
| Operating margin | -24.6% | -41.3% | +16.7 pp |
| Net income | -$49.3M | -$66.4M | +25.8% |
| Diluted EPS | -$0.08 | -$0.13 | +38.5% |
| Operating cash flow | -$84.1M | -$23.2M | -261.7% |
| Capex | $26M | $32M | -18.7% |
| Free cash flow | -$110M | -$55.3M | -99.2% |
| R&D | $82.4M | $66.1M | +24.6% |
| Stock-based compensation | $19.6M | $17.9M | +9.1% |
Reported vs consensus
2026-08-10| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $234M | $232M | +1.1% |
| EPS (as estimated) | -$0.08 | -$0.06 | -37.2% |
From the report of 2026-08-10 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q1 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Product | $127M | +57.8% | 63.6% | – | – | |
| Space Systems | – | – | – | – | – | |
| Service | $72.9M | +74.5% | 36.4% | – | – | |
| Launch Services | – | – | – | – | – |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- -$222M
- Capex
- -$149M
- Buybacks
- $0
- Dividends
- $0
- Acquisitions
- -$176M
- Net debt issued
- -$75.3M
- Stock-based compensation
- $81.6M
- Free cash flow
- -$371M
- Returned to shareholders / FCF
- 0.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | -197.7× | – | – |
| EV / EBITDA | -252.1× | – | – |
| EV / Sales | 40.0× | 37.8× | 7.9× – 80.2× |
| Price / FCF | -88.3× | – | – |
| Price / Book | 9.9× | 14.0× | 2.6× – 33.0× |
| FCF yield | -1.1% | -3.6% | -8.5% – -0.9% |
| Return on invested capital | -5.3% | -16.7% | -24.2% – -10.1% |
| Return on equity | -7.6% | -26.2% | -49.7% – -11.5% |
Analysts
Consensus target $105.17 (+92.2%)
range $80.00 – $132.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $959M | +59.4% | -$0.29 | +22.7% | -191.4× | 9 |
| FY2027 | $1.36B | +42.3% | -$0.04 | +85.4% | -1,313.4× | 10 |
| FY2028 | $1.83B | +34.3% | $0.26 | +719.3% | 212.1× | 6 |
| FY2029 | $2.22B | +21.2% | $0.49 | +89.9% | 111.7× | 3 |
| FY2030 | $2.7B | +21.3% | $0.84 | +71.0% | 65.3× | 2 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 286 figures Rocket Lab USA, Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $74.5M | $71M | +4.9% | $72.7M | $53.1M | +37.0% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $113M | $61.8M | +82.7% | $39M | $36.4M | +7.0% |
| Accretion (Amortization) of Discounts and Premiums, Investments | $415K | $538K | -22.9% | $2.25M | $2.9M | -22.6% |
| Accrued Liabilities, Current | $44.2M | $23.2M | +90.5% | $19.3M | $19.5M | -0.8% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $105M | $78.7M | +33.7% | $90.9M | $65.6M | +38.5% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$8.58M | $705K | -1,316.3% | -$1.96M | -$2.81M | +30.0% |
| Additional Paid in Capital | $4.61B | $1.63B | +182.9% | $2.74B | $1.2B | +128.2% |
| Adjustments to Additional Paid in Capital, Warrant Issued | – | – | – | $2.6M2023-12-31 | – | – |
| Amortization of Debt Issuance Costs | $46K | $860K | -94.7% | $3.14M | $3.09M | +1.6% |
| Amortization of Intangible Assets | $10.8M | $2.57M | +318.9% | $18M | $12.1M | +48.8% |
| APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | $21.5M | $18.7M | +15.0% | $69.9M | $55.9M | +25.1% |
| Assets | $4.19B | $1.55B | +169.6% | $2.32B | $1.18B | +96.3% |
| Assets, Current | $2.9B | $1.01B | +187.8% | $1.37B | $693M | +97.2% |
| Assets, Fair Value Disclosure | $2.3B | – | – | $1.01B | $420M | +141.1% |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $199K | $0 | – | -$10.6M | -$218K | -4,773.4% |
| Business Combination, Contingent Consideration, Liability, Noncurrent | $13.7M | – | – | $7.63M | – | – |
| Capital Expenditures Incurred but Not yet Paid | -$5.76M | $3.56M | -261.7% | – | – | – |
| Cash and Cash Equivalents, at Carrying Value | $2.13B | $564M | +277.5% | $829M | $271M | +205.7% |
| Cash Equivalents, at Carrying Value | $2.04B | $490M | +315.8% | $743M | $212M | +251.1% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $2.14B | $569M | +275.7% | $834M | $275M | +202.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $927M | $261M | +255.5% | $558M | $109M | +412.8% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 2.5B | 2.5B | 0.0% | 2.5B | 2.5B | 0.0% |
| Common Stock, Shares, Issued | 639M | 525M | +21.7% | 590M | 504M | +16.9% |
| Common Stock, Shares, Outstanding | 598M | 479M | +24.8% | 544M | 504M | +7.8% |
| Common Stock, Value, Issued | $60K | $48K | +25.0% | $54K | $50K | +8.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | -$54.9M | -$63.3M | +13.4% | -$197M | -$195M | -1.5% |
| Contract with Customer, Asset, after Allowance for Credit Loss | $94.2M | $51.9M | +81.5% | $61.6M | $63.1M | -2.4% |
| Contract with Customer, Asset, after Allowance for Credit Loss, Current | $94.2M | $51.9M | +81.5% | $61.6M | $63.1M | -2.4% |
| Contract with Customer, Liability | $351M | $223M | +57.2% | $195M | $216M | -9.6% |
| Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price | -$3.2M2025-12-31 | – | – | -$7.92M | – | – |
| Contract with Customer, Liability, Current | $351M | $223M | +57.2% | $195M | $216M | -9.6% |
| Contract with Customer, Liability, Revenue Recognized | $41.3M | – | – | – | – | – |
| Contract with Customer, Receivable, after Allowance for Credit Loss | $113M | $61.8M | +82.7% | $39M | $36.4M | +7.0% |
| Conversion of Stock, Amount Issued | – | – | – | $197M | $0 | – |
| Cost of Revenue | $149M | $98.1M | +52.4% | $395M | $320M | +23.3% |
| Current Federal Tax Expense (Benefit) | – | – | – | $0 | $0 | – |
| Current Foreign Tax Expense (Benefit) | – | – | – | $2.71M | -$299K | +1,007.7% |
| Current Income Tax Expense (Benefit) | – | – | – | $2.72M | -$285K | +1,053.7% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $4K | $14K | -71.4% |
| Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction | -$522K | -$527K | +0.9% | $214K | $0 | – |
| Debt Securities, Available-for-sale | $2.3B | $676M | +240.0% | $1.01B | $420M | +141.1% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | $51K | $247K | -79.4% | $412K | $281K | +46.6% |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | $528K | $30K | +1,660.0% | $17K | $103K | -83.5% |
| Debt Securities, Available-for-sale, Amortized Cost | $2.3B | $675M | +240.2% | $1.01B | $420M | +141.1% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | $2.21B | $614M | +260.0% | $931M | $359M | +158.9% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | $2.05M2025-09-30 | $45.5M | -95.5% | $42.4M2024-12-31 | $3.54M | +1,099.7% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | $1K2025-09-30 | $46K | -97.8% | $15K2024-12-31 | $18K | -16.7% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | $185M | $34.3M | +440.5% | $25.2M | $31.7M | -20.5% |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | $528K | $30K | +1,660.0% | $17K | $88K | -80.7% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | $2.21B | $614M | +259.9% | $931M | $360M | +158.9% |
| Debt Securities, Available-for-sale, Unrealized Loss Position | $18.1M2025-09-30 | $60.7M | -70.1% | $74.1M2024-12-31 | $102M | -27.1% |
| Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | $4K2025-09-30 | $56K | -92.9% | $103K2024-12-31 | $369K | -72.1% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$27.8M | $166K | -16,862.0% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $1.71M | $603K | +183.6% |
| Deferred Income Tax Assets, Net | $1.06M | $2.1M | -49.6% | $1.9M | $3.01M | -37.0% |
| Deferred Income Tax Expense (Benefit) | – | – | – | -$30.4M | $1.05M | -2,998.6% |
| Deferred Income Tax Liabilities, Net | $10.1M | $1.18M | +757.7% | $1.24M | $891K | +39.3% |
| Deferred Income Taxes and Tax Credits | $254K | $2.04M | -87.5% | -$30.7M | $599K | -5,219.7% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | -$4.29M | $280K | -1,632.5% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
Data as of 2026-11-02